Behcet’s syndrome is linked to several skin symptoms, including genital ulcers, aphthous ulcers, acne-like lesions, and painful red lesions known as erythema nodosum. These lesions are caused by inflammation of the subcutaneous fat and are commonly found on the shins. In contrast, erythema marginatum is a rare rash characterized by pink rings on the extensor surfaces and is associated with rheumatic fever. Asteatotic eczema, also known as crazy paving eczema, has a unique appearance and is linked to hypothyroidism and lymphoma.

Behcet’s syndrome is a complex disorder that affects multiple systems in the body. It is believed to be caused by inflammation of the arteries and veins due to an autoimmune response, although the exact cause is not yet fully understood. The condition is more common in the eastern Mediterranean, particularly in Turkey, and tends to affect young adults between the ages of 20 and 40. Men are more commonly affected than women, although this varies depending on the country. Behcet’s syndrome is associated with a positive family history in around 30% of cases and is linked to the HLA B51 antigen.

The classic symptoms of Behcet’s syndrome include oral and genital ulcers, as well as anterior uveitis. Other features of the condition may include thrombophlebitis, deep vein thrombosis, arthritis, neurological symptoms such as aseptic meningitis, gastrointestinal problems like abdominal pain, diarrhea, and colitis, and erythema nodosum. Diagnosis of Behcet’s syndrome is based on clinical findings, as there is no definitive test for the condition. A positive pathergy test, where a small pustule forms at the site of a needle prick, can be suggestive of the condition. HLA B51 is also a split antigen that is associated with Behcet’s syndrome.

Isoniazid is the tuberculosis antibiotic that can lead to drug-induced lupus. Drug-induced lupus is a condition that shares some symptoms with systemic lupus erythematosus (SLE), but not all. It usually goes away once the patient stops taking the medication. Anti-histone antibodies are typically positive in drug-induced lupus, but less common in SLE. On the other hand, anti-dsDNA antibodies are present in more than half of SLE cases, but very rarely in drug-induced lupus. Procainamide and hydralazine are the most common drugs that cause drug-induced lupus, but isoniazid is the most likely cause from the list of tuberculosis antibiotics (and pyridoxine). Isoniazid is also known to cause peripheral neuropathy and hepatitis. Ethambutol is another tuberculosis antibiotic that does not cause drug-induced lupus, but can cause optic neuritis. Pyrazinamide is another tuberculosis antibiotic that does not cause drug-induced lupus, but can cause gout and hepatitis. Pyridoxine is vitamin B6 and is given to all patients taking isoniazid to prevent peripheral neuropathy. It does not cause drug-induced lupus.

Understanding Drug-Induced Lupus

Drug-induced lupus is a condition that shares some similarities with systemic lupus erythematosus, but not all of its typical features are present. Unlike SLE, renal and nervous system involvement is rare in drug-induced lupus. The good news is that this condition usually resolves once the drug causing it is discontinued.

The most common symptoms of drug-induced lupus include joint pain, muscle pain, skin rashes (such as the malar rash), and pulmonary issues like pleurisy. In terms of laboratory findings, patients with drug-induced lupus typically test positive for ANA (antinuclear antibodies) but negative for dsDNA (double-stranded DNA) antibodies. Anti-histone antibodies are found in 80-90% of cases, while anti-Ro and anti-Smith antibodies are only present in around 5% of cases.

The most common drugs that can cause drug-induced lupus are procainamide and hydralazine. Other less common culprits include isoniazid, minocycline, and phenytoin.

To prevent pathological fractures in bone metastases, bisphosphonates and denosumab are viable options. However, if the patient’s eGFR is less than 30, denosumab is the preferred choice. Alendronic acid should be avoided due to the patient’s history of severe reflux during previous use. Denosumab is a novel treatment for osteoporosis that inhibits the development of osteoclasts by blocking RANKL. It is administered via subcutaneous injection and is also effective in preventing skeletal-related events in adults with bone metastases from solid tumors. Cinacalcet is not indicated for the management of osteoporosis or pathological fractures, but rather for hyperparathyroidism and hypercalcemia in parathyroid carcinoma. Hormone-replacement therapy (HRT) is not recommended for the treatment of osteoporosis in older postmenopausal women due to its unfavorable risk-benefit ratio.

Denosumab: A New Treatment for Osteoporosis

Denosumab is a human monoclonal antibody that inhibits the development of osteoclasts, which are responsible for breaking down bone tissue. It is administered as a subcutaneous injection every six months at a dose of 60mg. A larger dose of 120mg may be given every four weeks to prevent skeletal-related events in adults with bone metastases from solid tumors.

When it comes to managing osteoporosis, oral bisphosphonates are still the first-line treatment, with alendronate being the preferred option. If alendronate is not tolerated, an alternative bisphosphonate such as risedronate or etidronate may be used. Next-line medications are only started if certain T score and other risk factor criteria are met. Raloxifene and strontium ranelate were previously recommended as next-line drugs, but due to safety concerns regarding strontium ranelate, denosumab is becoming increasingly popular.

Denosumab is generally well-tolerated, with dyspnea and diarrhea being the most common side effects. However, doctors should be aware of the potential for atypical femoral fractures in patients taking denosumab and should look out for patients complaining of unusual thigh, hip, or groin pain.

Overall, denosumab is a promising new treatment for osteoporosis that may be particularly useful for patients who cannot tolerate oral bisphosphonates or who have other risk factors that make them unsuitable for these medications.

The patient is suffering from alcoholic neuropathy, which increases the risk of developing a Charcot joint (also known as neuropathic arthropathy). This condition gradually damages weight-bearing joints due to loss of sensation, leading to continued damage without pain awareness. While diabetic neuropathy is the most common cause, other conditions such as alcoholic neuropathy, syphilis, and cerebral palsy can also lead to it. The X-ray results of osteolysis and joint dislocation, along with the clinical symptoms of a non-tender, swollen, red, and warm foot, are characteristic of an acute Charcot joint. Osteoarthritis (OA) may cause a swollen and red foot, but it would not produce the X-ray changes described in this case. The history of alcoholism and peripheral neuropathy makes OA less likely. Although alcoholism can increase the risk of heart failure, the patient has no other symptoms of heart failure, making it an unlikely cause. Rheumatoid arthritis (RA) is an inflammatory arthropathy that can affect any joint in the body, but the combination of alcoholism and radiological findings makes RA less likely than a Charcot joint.

A Charcot joint, also known as a neuropathic joint, is a joint that has been severely damaged due to a loss of sensation. In the past, they were commonly caused by syphilis, but now they are most often seen in diabetics. These joints are typically less painful than expected, but some degree of pain is still reported by 75% of patients. The joint is usually swollen, red, and warm. The condition involves extensive bone remodeling and fragmentation, particularly in the midfoot, as seen in patients with poorly controlled diabetes. Charcot joints are a serious condition that require prompt medical attention.

The underlying cause of Marfan syndrome is a genetic mutation in the fibrillin-1 protein, which plays a crucial role as a substrate for elastin.

Understanding Marfan’s Syndrome

Marfan’s syndrome is a genetic disorder that affects the connective tissue in the body. It is caused by a defect in the FBN1 gene on chromosome 15, which codes for the protein fibrillin-1. This disorder is inherited in an autosomal dominant pattern, meaning that a person only needs to inherit one copy of the defective gene from one parent to develop the condition. Marfan’s syndrome affects approximately 1 in 3,000 people.

The features of Marfan’s syndrome include a tall stature with an arm span to height ratio greater than 1.05, a high-arched palate, arachnodactyly (long, slender fingers), pectus excavatum (sunken chest), pes planus (flat feet), and scoliosis (curvature of the spine). In addition, individuals with Marfan syndrome may experience cardiovascular problems such as dilation of the aortic sinuses, mitral valve prolapse, and aortic aneurysm. They may also have lung issues such as repeated pneumothoraces. Eye problems are also common, including upwards lens dislocation, blue sclera, and myopia. Finally, dural ectasia, or ballooning of the dural sac at the lumbosacral level, may also occur.

In the past, the life expectancy of individuals with Marfan syndrome was around 40-50 years. However, with regular echocardiography monitoring and the use of beta-blockers and ACE inhibitors, this has improved significantly in recent years. Despite these improvements, aortic dissection and other cardiovascular problems remain the leading cause of death in individuals with Marfan syndrome.

DEXA scans are utilized to measure bone mineral density in individuals who are at risk of osteoporosis or have experienced fragility fractures. To assess the risk of osteoporosis, online tools such as FRAX or QFracture can be used. The DEXA scan results comprise a T score and a Z score. The T score compares your bone density to that of a healthy 30-year-old, while the Z score compares your bone density to someone of your age and body size. The Z score is adjusted for age, gender, and ethnic factors.

Osteoporosis is a condition that affects bone density and can lead to fractures. To diagnose osteoporosis, doctors use a DEXA scan, which measures bone mass. The results are compared to a young reference population, and a T score is calculated. A T score of -1.0 or higher is considered normal, while a score between -1.0 and -2.5 indicates osteopaenia, and a score below -2.5 indicates osteoporosis. The Z score is also calculated, taking into account age, gender, and ethnicity.

The patient is exhibiting all four of Kanavel’s signs of flexor tendon sheath infection, namely fixed flexion, fusiform swelling, tenderness, and pain on passive extension. Gout and pseudogout are mono-arthropathies that only affect one joint, whereas inflammatory arthritis typically has a more gradual onset. Although cellulitis is a possibility, the examination findings suggest that a flexor tendon sheath infection is more probable.

Infective tenosynovitis is a medical emergency that necessitates prompt identification and treatment. If left untreated, the flexor tendons will suffer irreparable damage, resulting in loss of function in the digit. If detected early, medical management with antibiotics and elevation may be sufficient, but surgical debridement is likely necessary.

Hand Diseases

Dupuytren’s contracture is a hand disease that causes the fingers to bend towards the palm and become fixed in a flexed position. It is caused by thickening and shortening of the tissues under the skin on the palm of the hand, which leads to contractures of the palmar aponeurosis. This condition is most common in males over 40 years of age and is associated with liver cirrhosis and alcoholism. Treatment involves surgical fasciectomy, but the condition may recur and surgical therapies carry risks of neurovascular damage.

Carpal tunnel syndrome is another hand disease that affects the median nerve at the carpal tunnel. It is characterized by altered sensation in the lateral three fingers and is more common in females. It may be associated with other connective tissue disorders and can occur following trauma to the distal radius. Treatment involves surgical decompression of the carpal tunnel or non-surgical options such as splinting and bracing.

There are also several miscellaneous hand lumps that can occur. Osler’s nodes are painful, red, raised lesions found on the hands and feet, while Bouchard’s nodes are hard, bony outgrowths or gelatinous cysts on the middle joints of fingers or toes and are a sign of osteoarthritis. Heberden’s nodes typically develop in middle age and cause a permanent bony outgrowth that often skews the fingertip sideways. Ganglion cysts are fluid-filled swellings near a joint that are usually asymptomatic but can be excised if troublesome.

Ankylosing spondylitis (AS) patients can often find relief from their symptoms through the use of nonsteroidal anti-inflammatory drugs (NSAIDs) alone, according to the most recent guidelines from the European League Against Rheumatism (EULAR). In fact, continuous NSAID therapy is recommended for those with active and persistent symptoms, as it has been shown to slow the progression of the disease. While systemic glucocorticoids are not effective for managing AS, intra-articular steroid injections may be helpful for peripheral joint or enthesitis issues. Of traditional disease-modifying antirheumatic drugs (DMARDs), only sulphasalazine has been found to be effective for peripheral joint involvement, but it does not work for those with axial joint involvement. For those with insufficiently controlled symptoms, TNF-alpha inhibitors such as etanercept, infliximab, or adalimumab are recommended, without significant difference in efficacy between the three.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

During active systemic lupus erythematosus (SLE), complement levels are typically reduced and can be utilized to track disease flares. Studies have demonstrated that decreased levels of C4a and C4b are linked to a higher likelihood of developing SLE.

Systemic lupus erythematosus (SLE) can be investigated through various tests, including antibody tests. ANA testing is highly sensitive, making it useful for ruling out SLE, but it has low specificity. About 99% of SLE patients are ANA positive. Rheumatoid factor testing is positive in 20% of SLE patients. Anti-dsDNA testing is highly specific (>99%), but less sensitive (70%). Anti-Smith testing is also highly specific (>99%), but only 30% of SLE patients test positive. Other antibody tests include anti-U1 RNP, SS-A (anti-Ro), and SS-B (anti-La).

Monitoring of SLE can be done through various markers, including inflammatory markers such as ESR. During active disease, CRP levels may be normal, but a raised CRP may indicate an underlying infection. Complement levels (C3, C4) are low during active disease due to the formation of complexes that lead to the consumption of complement. Anti-dsDNA titres can also be used for disease monitoring, but it is important to note that they are not present in all SLE patients. Proper monitoring of SLE is crucial for effective management of the disease.

Hydroxychloroquine is the preferred treatment for SLE, as it is considered the mainstay of long-term maintenance therapy. This is the correct answer for the patient in question, who exhibits symptoms of malar rash, arthritis, thrombocytopenia, leukopenia, and a positive antinuclear antibody. While other medications may be added depending on disease severity, all patients should be started on hydroxychloroquine at diagnosis.

Azathioprine is not the best answer, as it is typically used as a steroid-sparing agent in moderate to severe cases of SLE where initial measures have not been successful. It is not necessary for all patients with SLE.

Belimumab is also not the best answer, as it is typically used as an additional therapy in patients with active autoantibody-positive disease who are already receiving conventional immunosuppression. It is not indicated for all patients.

Prednisolone may be used to induce remission in SLE patients, but the goal is to eventually manage the disease without steroids. It is not the ideal long-term treatment for SLE.

Managing Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects various organs and tissues in the body. To manage SLE, several treatment options are available. Nonsteroidal anti-inflammatory drugs (NSAIDs) can help relieve joint pain and inflammation. It is also important to use sunblock to prevent skin damage and flare-ups triggered by sun exposure.

Hydroxychloroquine is considered the treatment of choice for SLE. It can help reduce disease activity and prevent flares. However, if SLE affects internal organs such as the kidneys, nervous system, or eyes, additional treatment may be necessary. In such cases, prednisolone and cyclophosphamide may be prescribed to manage inflammation and prevent organ damage.

To summarize, managing SLE involves a combination of medication and lifestyle changes. NSAIDs and sunblock can help manage symptoms, while hydroxychloroquine is the preferred treatment for reducing disease activity. If SLE affects internal organs, additional medication may be necessary to prevent organ damage.

Understanding Trigger Finger

Trigger finger is a condition that affects the flexion of the digits, and is believed to be caused by a discrepancy in size between the tendon and pulleys through which they pass. This results in the tendon becoming stuck and unable to move smoothly through the pulley. While the majority of cases are idiopathic, trigger finger is more common in women than men and is associated with conditions such as rheumatoid arthritis and diabetes mellitus.

The condition typically affects the thumb, middle, or ring finger, and is characterized by stiffness and snapping when extending a flexed digit. A nodule may also be felt at the base of the affected finger. Management of trigger finger often involves steroid injections, which are successful in the majority of patients. A finger splint may be applied afterwards. Surgery is typically reserved for patients who have not responded to steroid injections. While there is some suggestion of a link between trigger finger and repetitive use, evidence to support this is limited.

ANCA Associated Vasculitis: Common Findings and Management

Anti-neutrophil cytoplasmic antibodies (ANCA) are associated with small-vessel vasculitides such as granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, and microscopic polyangiitis. ANCA associated vasculitis is more common in older individuals and presents with renal impairment, respiratory symptoms, systemic symptoms, and sometimes a vasculitic rash or ear, nose, and throat symptoms. First-line investigations include urinalysis, blood tests for renal function and inflammation, ANCA testing, and chest x-ray. There are two main types of ANCA – cytoplasmic (cANCA) and perinuclear (pANCA) – with varying levels found in different conditions. ANCA associated vasculitis should be managed by specialist teams and the mainstay of treatment is immunosuppressive therapy.

ANCA associated vasculitis is a group of small-vessel vasculitides that are associated with ANCA. These conditions are more common in older individuals and present with renal impairment, respiratory symptoms, systemic symptoms, and sometimes a vasculitic rash or ear, nose, and throat symptoms. To diagnose ANCA associated vasculitis, first-line investigations include urinalysis, blood tests for renal function and inflammation, ANCA testing, and chest x-ray. There are two main types of ANCA – cytoplasmic (cANCA) and perinuclear (pANCA) – with varying levels found in different conditions. ANCA associated vasculitis should be managed by specialist teams and the mainstay of treatment is immunosuppressive therapy.

The most likely diagnosis for the patient in the vignette is polymyositis, as she presents with true bilateral proximal muscle weakness, shortness of breath, and fatigue, along with elevated ESR and CK levels indicating muscle inflammation and injury. Dermatomyositis is less likely as no skin changes are mentioned. Motor neurone disease is also unlikely as it does not cause muscle tissue inflammation or elevated CK levels. Polymyalgia rheumatica is also unlikely as it does not present with true muscle weakness and is not associated with elevated CK levels.

Polymyositis: An Inflammatory Disorder Causing Muscle Weakness

Polymyositis is an inflammatory disorder that causes symmetrical, proximal muscle weakness. It is believed to be a T-cell mediated cytotoxic process directed against muscle fibers and can be idiopathic or associated with connective tissue disorders. This condition is often associated with malignancy and typically affects middle-aged women more than men.

One variant of the disease is dermatomyositis, which is characterized by prominent skin manifestations such as a purple (heliotrope) rash on the cheeks and eyelids. Other features of polymyositis include Raynaud’s, respiratory muscle weakness, dysphagia, and dysphonia. Interstitial lung disease, such as fibrosing alveolitis or organizing pneumonia, is seen in around 20% of patients and indicates a poor prognosis.

To diagnose polymyositis, doctors may perform various tests, including an elevated creatine kinase, EMG, muscle biopsy, and anti-synthetase antibodies. Anti-Jo-1 antibodies are seen in a pattern of disease associated with lung involvement, Raynaud’s, and fever.

The management of polymyositis involves high-dose corticosteroids tapered as symptoms improve. Azathioprine may also be used as a steroid-sparing agent. Overall, polymyositis is a challenging condition that requires careful management and monitoring.

Exercise is typically beneficial for inflammatory back pain, such as that seen in ankylosing spondylitis. The patient’s symptoms, including morning stiffness and improvement with exercise, suggest an inflammatory cause, which is supported by the significantly elevated ESR. While there are several possible diagnoses, including seropositive and seronegative spondyloarthropathies, the most likely explanation is ankylosing spondylitis. Psoriatic arthritis is an incorrect answer, as the patient’s rash is more consistent with dermatitis than psoriasis. Osteoarthritis is also unlikely given the patient’s age and clinical history, while reactive arthritis is less likely due to the duration of symptoms and lack of urethritis or conjunctivitis.

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in young males, with a sex ratio of 3:1, and typically presents with lower back pain and stiffness that develops gradually. The stiffness is usually worse in the morning and improves with exercise, while pain at night may improve upon getting up. Clinical examination may reveal reduced lateral and forward flexion, as well as reduced chest expansion. Other features associated with ankylosing spondylitis include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, amyloidosis, cauda equina syndrome, and peripheral arthritis (more common in females).

The primary investigation for patients suspected of having septic arthritis is the sampling of synovial fluid.

Septic arthritis is a joint inflammation caused by the introduction of infectious microorganisms into the joint.

Septic Arthritis in Adults: Causes, Symptoms, and Treatment

Septic arthritis is a condition that occurs when bacteria infect a joint, leading to inflammation and pain. The most common organism that causes septic arthritis in adults is Staphylococcus aureus, but in young adults who are sexually active, Neisseria gonorrhoeae is the most common organism. The infection usually spreads through the bloodstream from a distant bacterial infection, such as an abscess. The knee is the most common location for septic arthritis in adults. Symptoms include an acute, swollen joint, restricted movement, warmth to the touch, and fever.

To diagnose septic arthritis, synovial fluid sampling is necessary and should be done before administering antibiotics if necessary. Blood cultures may also be taken to identify the cause of the infection. Joint imaging may also be used to confirm the diagnosis.

Treatment for septic arthritis involves intravenous antibiotics that cover Gram-positive cocci. Flucloxacillin or clindamycin is recommended if the patient is allergic to penicillin. Antibiotic treatment is typically given for several weeks, and patients are usually switched to oral antibiotics after two weeks. Needle aspiration may be used to decompress the joint, and arthroscopic lavage may be required in some cases.

According to the updated NICE guidelines in 2016, NSAIDs are now the first choice for managing lower back pain. The recommended NSAIDs are ibuprofen or naproxen, and it is advisable to consider co-administration of PPI. Paracetamol alone is not recommended for lower back pain, and for patients who cannot tolerate NSAIDs, co-codamol should be considered. If patients report spasms as a feature of their pain, a short course of benzodiazepines may be considered. NICE recommends referring patients to physiotherapy only if they are at higher risk of back pain disability or if their symptoms have not improved at follow-up. Additionally, there may be some delay in attending physiotherapy, and NSAIDs can be started immediately.

Management of Non-Specific Lower Back Pain

Lower back pain is a common condition that affects many people. In 2016, NICE updated their guidelines on the management of non-specific lower back pain. The guidelines recommend NSAIDs as the first-line treatment for back pain. Lumbar spine x-rays are not recommended, and MRI should only be offered to patients where malignancy, infection, fracture, cauda equina or ankylosing spondylitis is suspected.

Patients with non-specific back pain are advised to stay physically active and exercise. NSAIDs are recommended as the first-line analgesia, and proton pump inhibitors should be co-prescribed for patients over the age of 45 years who are given NSAIDs. For patients with sciatica, NICE guidelines on neuropathic pain should be followed.

Other possible treatments include exercise programmes and manual therapy, but only as part of a treatment package including exercise, with or without psychological therapy. Radiofrequency denervation and epidural injections of local anaesthetic and steroid may also be considered for acute and severe sciatica.

In summary, the management of non-specific lower back pain involves encouraging self-management, staying physically active, and using NSAIDs as the first-line analgesia. Other treatments may be considered as part of a treatment package, depending on the severity of the condition.

The symptoms indicate the possibility of dermatomyositis, and the presence of anti-Jo 1 antibody can aid in confirming the diagnosis.

Dermatomyositis is a condition that causes inflammation and muscle weakness, as well as distinct skin lesions. It can occur on its own or be associated with other connective tissue disorders or underlying cancers, particularly ovarian, breast, and lung cancer. Screening for cancer is often done after a diagnosis of dermatomyositis. Polymyositis is a variant of the disease that does not have prominent skin manifestations.

The skin features of dermatomyositis include a photosensitive macular rash on the back and shoulders, a heliotrope rash around the eyes, roughened red papules on the fingers’ extensor surfaces (known as Gottron’s papules), extremely dry and scaly hands with linear cracks on the fingers’ palmar and lateral aspects (known as mechanic’s hands), and nail fold capillary dilation. Other symptoms may include proximal muscle weakness with tenderness, Raynaud’s phenomenon, respiratory muscle weakness, interstitial lung disease (such as fibrosing alveolitis or organizing pneumonia), dysphagia, and dysphonia.

Investigations for dermatomyositis typically involve testing for ANA antibodies, which are positive in around 80% of patients. Approximately 30% of patients have antibodies to aminoacyl-tRNA synthetases, including antibodies against histidine-tRNA ligase (also called Jo-1), antibodies to signal recognition particle (SRP), and anti-Mi-2 antibodies.

Paediatric Fractures and Pathological Conditions

Paediatric fractures can be classified into different types based on the injury pattern. Complete fractures occur when both sides of the cortex are breached, while greenstick fractures only have a unilateral cortical breach. Buckle or torus fractures result in incomplete cortical disruption, leading to a periosteal haematoma. Growth plate fractures are also common in paediatric practice and are classified according to the Salter-Harris system. Injuries of Types III, IV, and V usually require surgery and may be associated with disruption to growth.

Non-accidental injury is a concern in paediatric fractures, especially when there is a delay in presentation, lack of concordance between proposed and actual mechanism of injury, multiple injuries, injuries at sites not commonly exposed to trauma, or when children are on the at-risk register. Pathological fractures may also occur due to genetic conditions such as osteogenesis imperfecta, which is characterized by defective osteoid formation and failure of collagen maturation in all connective tissues. Osteopetrosis is another pathological condition where bones become harder and more dense, and radiology reveals a lack of differentiation between the cortex and the medulla, described as marble bone.

Overall, paediatric fractures and pathological conditions require careful evaluation and management to ensure optimal outcomes for the child.

Tuberculosis (TB) can lead to reactive arthritis, which can present as polyarthritis. In this case, the patient’s history of being a healthcare worker in a TB-endemic area, along with symptoms such as fever, weight loss, painless lymphadenopathy, and erythema nodosum, suggest the possibility of extrapulmonary TB. While C-reactive protein (CRP) levels may be elevated in any inflammatory arthritis, negative results for anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF) autoantibodies make rheumatoid arthritis less likely. Pseudogout can be ruled out through joint aspiration, which would reveal calcium pyrophosphate crystals. Systemic lupus erythematosus (SLE) is another potential cause of polyarthritis, but the patient’s Bangladeshi origin, healthcare worker background, and painless lymphadenopathy make TB a more likely diagnosis than SLE.

Possible Causes of Polyarthritis

Polyarthritis is a condition characterized by inflammation of multiple joints. There are several possible causes of polyarthritis, including rheumatoid arthritis, systemic lupus erythematosus (SLE), seronegative spondyloarthropathies, Henoch-Schonlein purpura, sarcoidosis, tuberculosis, pseudogout, and viral infections such as Epstein-Barr virus (EBV), HIV, hepatitis, mumps, and rubella.

Rheumatoid arthritis is a chronic autoimmune disorder that primarily affects the joints, causing pain, stiffness, and swelling. SLE is another autoimmune disease that can affect multiple organs, including the joints, skin, kidneys, and nervous system. Seronegative spondyloarthropathies are a group of inflammatory diseases that primarily affect the spine and sacroiliac joints, but can also involve other joints. Henoch-Schonlein purpura is a rare condition that causes inflammation of the blood vessels, leading to joint pain, skin rash, and abdominal pain. Sarcoidosis is a systemic disease that can affect various organs, including the joints, lungs, and eyes. Tuberculosis can also cause joint inflammation, especially in the spine. Pseudogout is a type of arthritis that is caused by the deposition of calcium pyrophosphate crystals in the joints. Finally, viral infections can cause joint pain and swelling, although this is usually a self-limited condition that resolves on its own.

In summary, polyarthritis can have various causes, ranging from autoimmune disorders to infectious diseases. A thorough evaluation by a healthcare provider is necessary to determine the underlying cause and appropriate treatment.

The correct diagnosis for this patient is anterior ischemic optic neuropathy, which is often associated with GCA or temporal arthritis. The fundoscopic examination typically reveals a pale and swollen optic disc with blurred margins. Age-related macular degeneration is an unlikely differential diagnosis as it presents with drusen on the retina. Amaurosis fugax, which is characterized by sudden and transient visual loss, is also an unlikely diagnosis as it does not fit with the patient’s prolonged visual impairment. Diabetic retinopathy, which is characterized by cotton wool spots and neovascularization, is also an unlikely diagnosis in this case.

Temporal arthritis, also known as giant cell arthritis, is a condition that affects medium and large-sized arteries and is of unknown cause. It typically occurs in individuals over the age of 50, with the highest incidence in those in their 70s. Early recognition and treatment are crucial to minimize the risk of complications, such as permanent loss of vision. Therefore, when temporal arthritis is suspected, urgent referral for assessment by a specialist and prompt treatment with high-dose prednisolone is necessary.

Temporal arthritis often overlaps with polymyalgia rheumatica, with around 50% of patients exhibiting features of both conditions. Symptoms of temporal arthritis include headache, jaw claudication, and tender, palpable temporal artery. Vision testing is a key investigation in all patients, as anterior ischemic optic neuropathy is the most common ocular complication. This results from occlusion of the posterior ciliary artery, leading to ischemia of the optic nerve head. Fundoscopy typically shows a swollen pale disc and blurred margins. Other symptoms may include aching, morning stiffness in proximal limb muscles, lethargy, depression, low-grade fever, anorexia, and night sweats.

Investigations for temporal arthritis include raised inflammatory markers, such as an ESR greater than 50 mm/hr and elevated CRP. A temporal artery biopsy may also be performed, and skip lesions may be present. Treatment for temporal arthritis involves urgent high-dose glucocorticoids, which should be given as soon as the diagnosis is suspected and before the temporal artery biopsy. If there is no visual loss, high-dose prednisolone is used. If there is evolving visual loss, IV methylprednisolone is usually given prior to starting high-dose prednisolone. Urgent ophthalmology review is necessary, as visual damage is often irreversible. Other treatments may include bone protection with bisphosphonates and low-dose aspirin.

Classification of Hypersensitivity Reactions

Hypersensitivity reactions are classified into four types according to the Gell and Coombs classification. Type I, also known as anaphylactic hypersensitivity, occurs when an antigen reacts with IgE bound to mast cells. This type of reaction is responsible for anaphylaxis and atopy, such as asthma, eczema, and hay fever. Type II, or cytotoxic hypersensitivity, happens when cell-bound IgG or IgM binds to an antigen on the cell surface. This type of reaction is associated with autoimmune hemolytic anemia, ITP, Goodpasture’s syndrome, and other conditions. Type III, or immune complex hypersensitivity, occurs when free antigen and antibody (IgG, IgA) combine to form immune complexes. This type of reaction is responsible for serum sickness, systemic lupus erythematosus, post-streptococcal glomerulonephritis, and extrinsic allergic alveolitis. Type IV, or delayed hypersensitivity, is T-cell mediated and is responsible for tuberculosis, graft versus host disease, allergic contact dermatitis, and other conditions.

In recent times, a fifth category has been added to the classification of hypersensitivity reactions. Type V hypersensitivity occurs when antibodies recognize and bind to cell surface receptors, either stimulating them or blocking ligand binding. This type of reaction is associated with Graves’ disease and myasthenia gravis. Understanding the different types of hypersensitivity reactions is important in diagnosing and treating various conditions. Proper identification of the type of reaction can help healthcare professionals provide appropriate treatment and management strategies.

The patient’s symptoms suggest an S1 lesion, as evidenced by sensory loss in the posterolateral aspect of the leg and lateral aspect of the foot, weakness in plantar flexion of the foot, reduced ankle reflex, and a positive sciatic nerve stretch test. L3, L4, and L5 are not the correct answer as their respective nerve root involvement would cause different symptoms.

Understanding Prolapsed Disc and its Features

A prolapsed lumbar disc is a common cause of lower back pain that can lead to neurological deficits. It is characterized by clear dermatomal leg pain, which is usually worse than the back pain. The pain is often aggravated when sitting. The features of the prolapsed disc depend on the site of compression. For instance, L3 nerve root compression can cause sensory loss over the anterior thigh, weak quadriceps, reduced knee reflex, and a positive femoral stretch test. On the other hand, L4 nerve root compression can lead to sensory loss in the anterior aspect of the knee, weak quadriceps, reduced knee reflex, and a positive femoral stretch test.

The management of prolapsed disc is similar to that of other musculoskeletal lower back pain. It involves analgesia, physiotherapy, and exercises. According to NICE, the first-line treatment for back pain without sciatica symptoms is NSAIDs +/- proton pump inhibitors, rather than neuropathic analgesia. If the symptoms persist after 4-6 weeks, referral for consideration of MRI is appropriate. Understanding the features of prolapsed disc can help in the diagnosis and management of this condition.

Medial epicondylitis, also known as golfers’ elbow, is a condition where the tendons of the wrist flexors become damaged due to repetitive use of these muscles. A patient presenting with pain at the medial epicondyle, such as a golf player, is likely to have this condition. Examination of the patient would reveal worsening symptoms when the wrist is flexed and pronated, as this aggravates the wrist flexor muscles at their common attachment point on the medial epicondyle of the humerus.

If a patient has a fluctuant swelling over the olecranon process, it suggests olecranon bursitis, which is caused by inflammation of the fluid-filled bursa overlying the olecranon process. This condition would present with swelling, pain, and tenderness over the olecranon process, rather than the medial epicondyle.

It is incorrect to assume that worsening symptoms would occur with the wrist extended and pronated or extended and supinated in a patient with medial epicondylitis. Lateral epicondylitis, also known as tennis elbow, would cause worsening symptoms when the wrist is extended and supinated, as this aggravates the wrist extensors at their insertion point on the lateral epicondyle of the humerus.

Understanding Medial Epicondylitis

Medial epicondylitis, commonly referred to as golfer’s elbow, is a condition characterized by pain and tenderness in the medial epicondyle. This area is located on the inner side of the elbow and is responsible for attaching the forearm muscles to the elbow. The pain is often aggravated by wrist flexion and pronation, which are movements commonly used in golf swings and other activities that involve repetitive gripping and twisting motions.

In addition to pain and tenderness, individuals with medial epicondylitis may also experience numbness or tingling in the fourth and fifth fingers due to ulnar nerve involvement. This nerve runs along the inner side of the elbow and can become compressed or irritated in cases of medial epicondylitis.

Overall, understanding the symptoms and causes of medial epicondylitis can help individuals take steps to prevent and manage this condition. This may include modifying activities that place strain on the elbow, using proper equipment and technique, and seeking medical treatment if symptoms persist.

Bisphosphonates: Uses and Adverse Effects

Bisphosphonates are drugs that mimic the action of pyrophosphate, a molecule that helps prevent bone demineralization. They work by inhibiting osteoclasts, which are cells that break down bone tissue. This reduces the risk of bone fractures and can be used to treat conditions such as osteoporosis, hypercalcemia, Paget’s disease, and pain from bone metastases.

However, bisphosphonates can have adverse effects, including oesophageal reactions such as oesophagitis and ulcers, osteonecrosis of the jaw, and an increased risk of atypical stress fractures of the proximal femoral shaft in patients taking alendronate. Patients may also experience an acute phase response, which can cause fever, myalgia, and arthralgia. Hypocalcemia, or low calcium levels, can also occur due to reduced calcium efflux from bone, but this is usually not clinically significant.

To minimize the risk of adverse effects, patients taking oral bisphosphonates should swallow the tablets whole with plenty of water while sitting or standing. They should take the medication on an empty stomach at least 30 minutes before breakfast or other oral medications and remain upright for at least 30 minutes after taking the tablet. Hypocalcemia and vitamin D deficiency should be corrected before starting bisphosphonate treatment, and calcium supplements should only be prescribed if dietary intake is inadequate. The duration of bisphosphonate treatment varies depending on the patient’s level of risk, and some authorities recommend stopping treatment after five years for low-risk patients with a femoral neck T-score of > -2.5.

Understanding Paget’s Disease of the Bone

Paget’s disease of the bone is a condition characterized by increased and uncontrolled bone turnover. It is believed to be caused by excessive osteoclastic resorption followed by increased osteoblastic activity. Although it is a common condition, affecting 5% of the UK population, only 1 in 20 patients experience symptoms. The most commonly affected areas are the skull, spine/pelvis, and long bones of the lower extremities. Predisposing factors include increasing age, male sex, northern latitude, and family history.

Symptoms of Paget’s disease include bone pain, particularly in the pelvis, lumbar spine, and femur. The stereotypical presentation is an older male with bone pain and an isolated raised alkaline phosphatase (ALP). Classical, untreated features include bowing of the tibia and bossing of the skull. Diagnosis is made through blood tests, which show raised ALP, and x-rays, which reveal osteolysis in early disease and mixed lytic/sclerotic lesions later.

Treatment is indicated for patients experiencing bone pain, skull or long bone deformity, fracture, or periarticular Paget’s. Bisphosphonates, either oral risedronate or IV zoledronate, are the preferred treatment. Calcitonin is less commonly used now. Complications of Paget’s disease include deafness, bone sarcoma (1% if affected for > 10 years), fractures, skull thickening, and high-output cardiac failure.

Overall, understanding Paget’s disease of the bone is important for early diagnosis and management of symptoms and complications.

The reactivation of TB is a possible side effect of TNF-α inhibitors.

Managing Rheumatoid Arthritis with Disease-Modifying Therapies

The management of rheumatoid arthritis (RA) has significantly improved with the introduction of disease-modifying therapies (DMARDs) in the past decade. Patients with joint inflammation should start a combination of DMARDs as soon as possible, along with analgesia, physiotherapy, and surgery. In 2018, NICE updated their guidelines for RA management, recommending DMARD monotherapy with a short course of bridging prednisolone as the initial step. Monitoring response to treatment is crucial, and NICE suggests using a combination of CRP and disease activity to assess it. Flares of RA are often managed with corticosteroids, while methotrexate is the most widely used DMARD. Other DMARDs include sulfasalazine, leflunomide, and hydroxychloroquine. TNF-inhibitors are indicated for patients with an inadequate response to at least two DMARDs, including methotrexate. Etanercept, infliximab, and adalimumab are some of the TNF-inhibitors available, each with their own risks and administration methods. Rituximab and Abatacept are other DMARDs that can be used, but the latter is not currently recommended by NICE.

In many instances, arthritis symptoms are identified prior to the onset of psoriasis. Symmetrical polyarthritis is a common manifestation of rheumatoid arthritis.

Psoriatic arthropathy is a type of inflammatory arthritis that is associated with psoriasis. It is classified as one of the seronegative spondyloarthropathies and is known to have a poor correlation with cutaneous psoriasis. In fact, it often precedes the development of skin lesions. This condition affects both males and females equally, with around 10-20% of patients with skin lesions developing an arthropathy.

The presentation of psoriatic arthropathy can vary, with different patterns of joint involvement. The most common type is symmetric polyarthritis, which is very similar to rheumatoid arthritis and affects around 30-40% of cases. Asymmetrical oligoarthritis is another type, which typically affects the hands and feet and accounts for 20-30% of cases. Sacroiliitis, DIP joint disease, and arthritis mutilans (severe deformity of fingers/hand) are other patterns of joint involvement. Other signs of psoriatic arthropathy include psoriatic skin lesions, periarticular disease, enthesitis, tenosynovitis, dactylitis, and nail changes.

To diagnose psoriatic arthropathy, X-rays are often used. These can reveal erosive changes and new bone formation, as well as periostitis and a pencil-in-cup appearance. Management of this condition should be done by a rheumatologist, and treatment is similar to that of rheumatoid arthritis. However, there are some differences, such as the use of monoclonal antibodies like ustekinumab and secukinumab. Mild peripheral arthritis or mild axial disease may be treated with NSAIDs alone, rather than all patients being on disease-modifying therapy as with RA. Overall, psoriatic arthropathy has a better prognosis than RA.

The most specific test for limited cutaneous systemic sclerosis among patients with systemic sclerosis is the anti-centromere antibodies.

Understanding Systemic Sclerosis

Systemic sclerosis is a condition that affects the skin and other connective tissues, but its cause is unknown. It is more common in females, with three patterns of the disease. Limited cutaneous systemic sclerosis is characterised by Raynaud’s as the first sign, affecting the face and distal limbs, and associated with anti-centromere antibodies. CREST syndrome is a subtype of limited systemic sclerosis that includes Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, and Telangiectasia. Diffuse cutaneous systemic sclerosis affects the trunk and proximal limbs, associated with scl-70 antibodies, and has a poor prognosis. Respiratory involvement is the most common cause of death, with interstitial lung disease and pulmonary arterial hypertension being the primary complications. Renal disease and hypertension are also possible complications, and patients with renal disease should be started on an ACE inhibitor. Scleroderma without internal organ involvement is characterised by tightening and fibrosis of the skin, manifesting as plaques or linear. Antibodies such as ANA, RF, anti-scl-70, and anti-centromere are associated with different types of systemic sclerosis.

Hand osteoarthritis is characterized by the involvement of the carpometacarpal and distal interphalangeal joints, with the presence of osteophytes at the base of the thumb and distal interphalangeal joints being a typical finding. Lytic bone lesions are unlikely to be the cause of this presentation, as they are more commonly associated with metastasis or osteomyelitis. While rheumatoid arthritis can also involve the proximal interphalangeal joints and cause joint effusions, this woman’s age, history, and symptoms suggest that osteoarthritis is more likely. The pencil in cup appearance seen in psoriatic arthritis is not present in this case, as the patient does not report any skin lesions. Although most cases of osteoarthritis are asymptomatic, the patient’s symptoms suggest that some radiological changes have occurred.

Understanding Osteoarthritis of the Hand

Osteoarthritis of the hand, also known as nodal arthritis, is a condition that occurs when the cartilage at synovial joints is lost, leading to the degeneration of underlying bone. It is more common in women, usually presenting after the age of 55, and may have a genetic component. Risk factors include previous joint trauma, obesity, hypermobility, and certain occupations. Interestingly, osteoporosis may actually reduce the risk of developing hand OA.

Symptoms of hand OA include episodic joint pain, stiffness that worsens after periods of inactivity, and the development of painless bony swellings known as Heberden’s and Bouchard’s nodes. These nodes are the result of osteophyte formation and are typically found at the distal and proximal interphalangeal joints, respectively. In severe cases, there may be reduced grip strength and deformity of the carpometacarpal joint of the thumb, resulting in fixed adduction.

Diagnosis is typically made through X-ray, which may show signs of osteophyte formation and joint space narrowing before symptoms develop. While hand OA may not significantly impact a patient’s daily function, it is important to manage symptoms through pain relief and joint protection strategies. Additionally, the presence of hand OA may increase the risk of future hip and knee OA, particularly for hip OA.

Before administering bisphosphonates, it is important to address hypocalcemia and vitamin D deficiency.

Bisphosphonates: Uses and Adverse Effects

Bisphosphonates are drugs that mimic the action of pyrophosphate, a molecule that helps prevent bone demineralization. They work by inhibiting osteoclasts, which are cells that break down bone tissue. This reduces the risk of bone fractures and can be used to treat conditions such as osteoporosis, hypercalcemia, Paget’s disease, and pain from bone metastases.

However, bisphosphonates can have adverse effects, including oesophageal reactions such as oesophagitis and ulcers, osteonecrosis of the jaw, and an increased risk of atypical stress fractures of the proximal femoral shaft in patients taking alendronate. Patients may also experience an acute phase response, which can cause fever, myalgia, and arthralgia. Hypocalcemia, or low calcium levels, can also occur due to reduced calcium efflux from bone, but this is usually not clinically significant.

To minimize the risk of adverse effects, patients taking oral bisphosphonates should swallow the tablets whole with plenty of water while sitting or standing. They should take the medication on an empty stomach at least 30 minutes before breakfast or other oral medications and remain upright for at least 30 minutes after taking the tablet. Hypocalcemia and vitamin D deficiency should be corrected before starting bisphosphonate treatment, and calcium supplements should only be prescribed if dietary intake is inadequate. The duration of bisphosphonate treatment varies depending on the patient’s level of risk, and some authorities recommend stopping treatment after five years for low-risk patients with a femoral neck T-score of > -2.5.